Indefinite Delivery Contract 75N93025D00011

Award Date 9/15/25
Last Date to Order 9/14/32
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract indefinite delivery vehicle (IDV) award from the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) is a single-award contract with Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization. The $5 million, 5-year IDV is for receptor binding and predictive toxicology services to support the agency's drug abuse research programs. Under this IDV, two delivery orders have been issued to...
The federal contract IDV is an Indefinite Delivery Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services. The single-award contract, valued at a ceiling of $50,000,000, was awarded to the non-profit research organization Research Triangle Institute (RTI International) on September 15, 2025, with a period of performance extending until September 14, 2032. The contract is for...
The federal contract IDV award is a single-award Indefinite Delivery Contract issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Pharmacology Discovery Services Taiwan, LTD., a for-profit Taiwanese organization. The contract, valued up to $146.3M, supports NIAID's preclinical infectious disease research by providing a range of animal and animal replacement models for screening and evaluating candidate countermeasures such as therapeutics, vaccines,...
The federal contract IDV award, with an ID of 75N93024D00022, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). This single-award Indefinite Delivery Contract, potentially valued up to $146,300,000, is for pre-clinical models of infectious diseases under task areas A, B, and C. The prime contractor, Texas Biomedical Research Institute, will provide a range of services including developing...
The federal contract IDV award is for an Indefinite Delivery Contract with a ceiling value of $146,300,000 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is focused on providing pre-clinical models of infectious diseases to support research, development, and evaluation of medical countermeasures such as therapeutics, vaccines, and diagnostics. The contract has a single award to...
This indefinite delivery contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Eurofins Discovery Services North America, LLC, a foreign-owned for-profit contract research organization. The $20 million single-award IDC is for research and development services and studies, with a period of performance through September 2028. Under this IDC, Eurofins has been issued two firm-fixed-price delivery orders. The first order, valued at $38,639.60, is for...
The federal contract IDV is an Indefinite Delivery Contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the non-profit research and development organization SRI International. The single-award contract has a $50,000,000.00 ceiling value and a performance period through September 14, 2032. The contract is for INTERVENTIONAL AGENTS CHEMISTRY SERVICES, providing SRI International's specialized research and technical capabilities to the...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract has a total ceiling value of $50,000,000 and a period of performance ending on September 14, 2032. The prime contractor is Research Triangle Institute (RTI International), a non-profit research organization headquartered in North Carolina. The contract is intended to provide NIAID with...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
The federal contract IDV award is for an Indefinite Delivery Contract with a ceiling value of $146,300,000 issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Pennsylvania State University doing business as Penn State Milton S. Hershey Medical Center. The contract has a period of performance through July 2031 and supports NIAID's Division of Microbiology and Infectious Diseases (DMID) research efforts. It aims to provide capability and...

The key products and services being delivered under this federal contract Indefinite Delivery Vehicle (IDV) award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, are interventional agents safety and pharmacokinetic services. The single-award IDV has a ceiling value of $50,000,000 and runs from September 15, 2025 through September 14, 2032. The prime contractor, Eurofins Discovery Services North America, LLC, is a foreign-owned, for-profit contract research organization registered in SAM.gov that specializes in advanced scientific research and development services. The company has been awarded multiple federal IDV contracts, demonstrating its capability to support complex scientific research initiatives across various federal departments. This IDV with NIAID allows the agency to access Eurofins' specialized services, which include receptor binding studies, toxicology testing, analytical chemistry, and non-clinical research methodologies. The contract does not utilize any small business set-asides.

Generated 9/16/25, 9:59 AM